Patents by Inventor Yoel Kashman

Yoel Kashman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6350743
    Abstract: Shermilamine D, a novel cytotoxic pyridoacridine alkaloid of Formula 1, has been isolated from the tunicate Cystodytes violatinctus. The structure of the compound has been established on the basis of 1-D and 2-D NMR data.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: February 26, 2002
    Assignee: Instituto Biomar, S.A.
    Inventors: Yoel Kashman, Ganit Koren-Goldshlager, Maurice Aknin, Dolores Garcia Gravalos
  • Patent number: 6303125
    Abstract: A non-food anti-microbial-adhesion and aggregation composition comprising a suitable carrier and an effective amount of an adhesion inhibitory fraction isolated from juice from berries of the Vaccinium plant genus. In an embodiment the anti-aggregation and adhesion fraction is isolated from cranberry juice. It is characterized as being polymeric and having a molecular weight ≧14,000; an elemental analysis of carbon 43-51%, hydrogen 4-5%, no nitrogen, no sulfur and no chlorine; a nuclear magnetic resonance (NMR) line spectrum as set forth in FIGS. 2A and 2B; and an ultraviolet spectrum with an absorption peak at 280 nm in neutral or acidic pH solution which is absent in alkali solutions. This fraction exhibits adhesion inhibitory activity against P fimbriated bacteria, oral bacteria and Helicobacter pylori.
    Type: Grant
    Filed: September 24, 1998
    Date of Patent: October 16, 2001
    Assignee: RAMOT-University Authority for Applied Research and Industrial Development Ltd.
    Inventors: Itzhak Ofek, Ervin Weiss, Yoel Kashman, Janina Goldhar, Nathan Sharon
  • Patent number: 5859049
    Abstract: The present invention provides novel antiviral compounds, refered to as calanolides, related compounds, and their derivatives, which may be isolated from plants, or derived from compounds from plants, of the genus Calophyllum in accordance with the present inventive method. The compounds and their derivatives may be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the growth or replication of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2.
    Type: Grant
    Filed: May 24, 1996
    Date of Patent: January 12, 1999
    Assignees: The United States of America as represented by the Department of Health and Human Services, The Board of Trustees of the University of Illinois
    Inventors: Michael R. Boyd, John H. Cardellina, II, Kirk R. Gustafson, James B. McMahon, Richard W. Fuller, Gordon M. Cragg, Yoel Kashman, Doel Soejarto
  • Patent number: 5840322
    Abstract: A non-food oral hygiene composition comprising a suitable carrier and an effective amount of an adhesion inhibitory fraction isolated from juice from berries of the Vaccinium plant genus. In a preferred embodiment the anti-aggregation fraction is isolated from cranberry juice. It is characterized as being polymeric and having a molecular weight .gtoreq.14,000; an elemental analysis of carbon 43-51%, hydrogen 4-5%, no nitrogen, no sulfur and no chlorine; an NMR line spectrum as set forth in FIGS. 2A and 2B; and an ultraviolet spectrum with an absorption peak at 280 nm in neutral or acidic pH solution which is absent in alkali solutions. This fraction exhibits adhesion inhibitory activity against both P fimbriated bacteria and oral bacteria.
    Type: Grant
    Filed: December 19, 1996
    Date of Patent: November 24, 1998
    Assignee: Ramot-University Authority For Applied Research & Industrial Devel. Ltd.
    Inventors: Ervin Weiss, Itzhak Ofek, Yoel Kashman, Janina Goldhar, Nathan Sharon
  • Patent number: 5661175
    Abstract: Three cytotoxic peptides, the known compound Jaspamide and two new peptides, hemiasterlin (Compound 2) and geodiamolide TA (Compound 3), have been isolated from the sponge Hemiasterella minor. The structures of the three were determined by interpreting the NMR and mass spectra. Hemiasterlin (Compound 2) is a novel linear tripeptide embodying two unique, new natural amino acids and geodiamolide TA (Compound 3) is a newly discovered higher homolog of geodiamolides A-F.
    Type: Grant
    Filed: June 20, 1995
    Date of Patent: August 26, 1997
    Inventors: Yoel Kashman, Dolores G. Gravalos
  • Patent number: 5591770
    Abstract: The present invention provides novel antiviral compounds, refered to as calanolides, related compounds, and their derivatives, which may be isolated from plants, or derived from compounds from plants, of the genus Calophyllum in accordance with the present inventive method. The compounds and their derivatives may be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the growth or replication of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2.
    Type: Grant
    Filed: May 21, 1993
    Date of Patent: January 7, 1997
    Assignees: The United States of America as represented by the Department of Health and Human Services, The Board of Trustees of the University of Illinois
    Inventors: Michael R. Boyd, John H. Cardellina, II, Kirk R. Gustafson, James B. McMahon, Richard W. Fuller, Gordon M. Cragg, Yoel Kashman, Doel Soejarto
  • Patent number: 5432172
    Abstract: Biological applications of synthetic and natural alkaloids derived from the tunicate Eudistoma sp. are disclosed. A method regulating cell growth includes contacting one or more cells with an effective concentration of a compound for regulating cell growth. These compounds include: Segoline A, Segoline B, Isosegoline A, Norosegoline, Debromoshermilamine, Eilatin, 4-methylpyrido[2,3,4-kl]acridine, pyrido[2,3,4-kl]acridine, 1-acetyl-2,6-dimethylpyrido[2,3,4-kl]acridine, and derivatives and combinations of these compounds. An effective concentration range for using these compounds can range from approximately 0.1 .mu.M to 100 .mu.M. The effective concentration range for Eilatin, the most potent of these compounds is from 0.01 .mu.M to 0.99 .mu.M, and the effective concentration range for the other compounds of the present invention is from about 1.0 .mu.M to 100 .mu.M.
    Type: Grant
    Filed: March 9, 1993
    Date of Patent: July 11, 1995
    Assignee: The Research Foundation of State University of New York
    Inventors: Ilan Spector, Nava R. Shochet, Yoel Kashman, Amira Rudi, Gary Gellerman
  • Patent number: 5278168
    Abstract: Biological applications of synthetic and natural alkaloids derived from the tunicate Eudistoma sp. are disclosed. A method regulating cell growth includes contacting one or more cells with an effective concentration of a compound for regulating cell growth. These compounds include: Segoline A, Segoline B, Isosegoline A, Norosegoline, Debromoshermilamine, Eilatin, 4-methylpyrido[2,3,4-kl] acridine, pyrido[2,3,4-kl]acridine, 1-acetyl-2,6-dimethylpyrido[2,3,4-kl]acridine, and derivatives and combinations of these compounds. An effective concentration range for using these compounds can range from approximately 0.1 .mu.M to 100 .mu.M. The effective concentration range for Eilatin, the most potent of these compounds is from 0.01 .mu.M to 0.99 .mu.M, and the effective concentration range for the other compounds of the present invention is from about 1.0 .mu.M to 100 .mu.M.
    Type: Grant
    Filed: August 3, 1992
    Date of Patent: January 11, 1994
    Assignee: The Research Foundation of State Univeristy of New York
    Inventors: Ilan Spector, Nava R. Shochet, Yoel Kashman, Amira Rudi
  • Patent number: 4970226
    Abstract: Novel brominated bisindole-imidazole alkaloids have been isolated from marine sponges. These compounds, and derivatives thereof, are useful antimicrobial and antitumor compounds.
    Type: Grant
    Filed: October 3, 1989
    Date of Patent: November 13, 1990
    Assignee: Harbor Branch Oceanographic Institution, Inc.
    Inventors: H. Howard Sun, Shinichi Sakemi, Sarath Gunasekera, Yoel Kashman, May Lui, Neal Burres, Peter McCarthy
  • Patent number: 4935439
    Abstract: This invention relates to antiviral organic compositions and derivatives thereof; a process of producing the antiviral compositions; and a method for inhibiting viruses utilizing the compositions. More particularly, the compositions are derived from marine sponges of the genus Epipolasis.
    Type: Grant
    Filed: August 31, 1987
    Date of Patent: June 19, 1990
    Assignee: Harbor Branch Oceanographic Institution, Inc.
    Inventors: Yoel Kashman, Shulamit Hirsch, Sue S. Cross, Frank Koehn
  • Patent number: 4866084
    Abstract: A new class of novel, biologically active bisindole alkaloid compounds, which have been named topsentins, pharmaceutical compositions containing them, methods of producing the compounds and methods of using them are disclosed. This new class of compounds has the generic formula: ##STR1## R.sup.1-8 are the same or different selected from --H, --OH, halogen, --R, --OR, --OCOR, or --OA;Y is the single group --O, or two groups, same or different, selected from --H, --OH, --OR, or --OCOR with the provision that Y shall not be two --OH groups;Z are the same or different selected from --H, --R;R is C1-5 alkyl and A is --R--phenyl.The compounds are antiviral agents and antitumor agents which are effective against specific tumors.
    Type: Grant
    Filed: December 19, 1988
    Date of Patent: September 12, 1989
    Assignee: Harbor Branch Oceanographic Institution, Inc.
    Inventors: Sarath P. Gunasekera, Sue S. Cross, Yoel Kashman, May S. Lui, Kenneth L. Rinehart, Shinji Tsujii
  • Patent number: 4857538
    Abstract: A compound, and composition including same, for effecting irreversible change in cell morphology having the following structures: ##STR1## wherein R is --(CH.sub.2).sub.n ZH in which n=1, 2, 3 and 4 and Z is O, S, or NH, and ##STR2## wherein R.sub.1 and R.sub.2 can be --OH, alkyl and acyl.
    Type: Grant
    Filed: November 30, 1987
    Date of Patent: August 15, 1989
    Assignee: The Research Foundation of State University of New York
    Inventors: Yoel Kashman, Ilan Spector, Shmuel Carmely, Dina Blasberger
  • Patent number: 4659704
    Abstract: There is provided the novel compound 19-hydroxyaldosterone. There is provided a process for its preparation. There are further provided pharmaceutical compositions comprising this compound as active ingredient. These are useful, amongst others, as mineralocorticoid drugs and as drug against Addison's disease.
    Type: Grant
    Filed: May 21, 1985
    Date of Patent: April 21, 1987
    Assignee: Ramot University Authority for Applied Research & Industrial Development Ltd.
    Inventors: Marcel Harnik, Yoel Kashman